Tuberville Questions Prescription Drug Manufacturers on Biden Regulations, Vax Mandate
February 08, 2024
February 08, 2024
WASHINGTON, Feb. 8 -- Sen. Tommy Tuberville, R-Alabama, issued the following news release:
In a Senate Health, Education, Labor, and Pension (HELP) Committee hearing today, U.S. Senator Tommy Tuberville (R-AL) questioned Chief Executive Officers (CEO) Joaquin Duato of Johnson & Johnson, Robert Davis of Merck, and Chris Boerner of Bristol Myers Squibb. Senator Tuberville questioned the three CEOs on the impact of federal regulations on cancer treatments as well as about the Biden . . .
In a Senate Health, Education, Labor, and Pension (HELP) Committee hearing today, U.S. Senator Tommy Tuberville (R-AL) questioned Chief Executive Officers (CEO) Joaquin Duato of Johnson & Johnson, Robert Davis of Merck, and Chris Boerner of Bristol Myers Squibb. Senator Tuberville questioned the three CEOs on the impact of federal regulations on cancer treatments as well as about the Biden . . .